Kindbody was once one of the fastest-growing fertility chains in the US. The venture-backed company cultivated a modern and millennial-friendly aesthetic that helped it attract more than $300 million in investments, including backing from celebrity investors like Gwyneth Paltrow and Chelsea Clinton. But Kindbody has been riddled with clinical problems, with embryos being mislabeled, lost or accidentally destroyed, and has spiraled into crisis. As more people seek fertility treatment than ever, the startup's story illustrates the dangers of moving fast in a largely unregulated industry.See omnystudio.com/listener for privacy information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Bloomberg Tech
Transcribed and ready to explore now
Meta Stock Surges on Plans for Metaverse Cuts
05 Dec 2025
Bloomberg Tech
Tech Left Behind in S&P 500’s Latest Rebound
03 Dec 2025
Bloomberg Tech
Nvidia Shares Fall on Reports of Google Competition
25 Nov 2025
Bloomberg Tech
Big Tech’s AI Debt Is Raising Investors’ Eyebrows
24 Nov 2025
Bloomberg Tech
Special Episode: Here's Why AI Costs Still Worry Investors
22 Nov 2025
Bloomberg Tech
AI, Crypto Anxiety Creates Volatile Week for Markets
21 Nov 2025
Bloomberg Tech